C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2006
12/14/2006	WO2006110827A3 Constricting gel assay and therapeutic patch
12/14/2006	WO2006108882A8 In vitro production of a cell population using feeder cells
12/14/2006	WO2006103452A3 Improved nitroreductase enzymes
12/14/2006	WO2006097743A3 Method for actvating natural killer cells by tumor cell preparation in vitro
12/14/2006	WO2006094673A3 Synergistic mixtures of c6- to c12-alkanedi0ls and tropolone (derivatives)
12/14/2006	WO2006076094A3 Process for constructing strain having compactin hydroxylation ability
12/14/2006	WO2006071563A3 Non-tumorigenic mdck cell line for propagating viruses
12/14/2006	WO2006051538A3 Cells isolated from placenta, device for isolating same, and uses thereof
12/14/2006	WO2006031539A3 Liver stromal cells for prevention and treatment of immune responses in transplantation
12/14/2006	WO2005081870A3 Intervertebral disc repair, methods and devices therefor
12/14/2006	WO2005079390A3 Inhibition of fgf signaling
12/14/2006	WO2005007116A3 Artificial antigen presenting cell devices
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060282921 Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells
12/14/2006	US20060282919 Nucleic acid that drives pollen-specific expression; down- or up-regulation of gene expression in pollen; producing a plant with reduced male fertility
12/14/2006	US20060282917 Modified starch, uses, methods for production thereof
12/14/2006	US20060282916 Genes controlling plant cell wall formation
12/14/2006	US20060282915 Soybean event MON89788 and methods for detection thereof
12/14/2006	US20060282914 Targeted dna insertion in plants
12/14/2006	US20060282912 Production of plants with improved digestibility having an inactive peroxidase
12/14/2006	US20060282910 Delphinium flower color crossing method
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060282907 Transgenic animal having fatty acid desaturase and method of producing the same
12/14/2006	US20060282173 Substantially decellularized grafts from umbilical cord vessels and process for preparing and using same
12/14/2006	US20060281910 Modulating gene expression in crop plants and transforming crop plants that display low transformation efficiencies with existing transformation methods
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281900 Lepidoptera voltage-gated calcium channels
12/14/2006	US20060281898 Method for the production of plant seed with modified fibre content and modified seed coat
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281181 Adaptor-directed helper systems
12/14/2006	US20060281179 Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
12/14/2006	US20060281178 Human stem cells originating from human amniotic mesenchymal cell layer
12/14/2006	US20060281177 Method of isolating epidermal neural crest stem cells
12/14/2006	US20060281176 In-Vitro fertilization systems with spermatozoa separated into X-chromosome and Y-chromosome bearing populations
12/14/2006	US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/14/2006	US20060281174 Methods for generating insulin-producing cells
12/14/2006	US20060281173 Composition for coating support for preparation of cell sheet support for preparation of cell sheet and process for producing cell sheet
12/14/2006	US20060281150 Preparing membrane receptors from extracellular baculoviruses
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281137 Method of the discrimination and isolation of mammary epithelial stem and colony-forming cells
12/14/2006	US20060281136 Preparation of endodermal stem cells
12/14/2006	US20060281131 Monoclonal antibodies; renal diseases; kits
12/14/2006	US20060281118 efficiently purifying proteasomes using fusion proteins having homology to ubiquitin; immobilizing ubiquitin amino acid sequence to solid support, incubate with cell lysate, elute proteasome from solid support
12/14/2006	US20060281111 isolated polyclonal antibody of given sequence; use in detecting, diagnosing, staging or monitoring progression of cancer, inflammatory, autoimmune, cardiovascular, and neurological disorders
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006	US20060281080 Novel lipases and uses thereof
12/14/2006	US20060280758 Modified vaccinia ankara virus variant
12/14/2006	US20060280757 Flavivirus vaccine delivery system
12/14/2006	US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	US20060280743 Immunoglobulin for treatment of alzheimer's diseases
12/14/2006	US20060280740 Compositions and methods for regulating NK cell activity
12/14/2006	US20060280734 Retargeting
12/14/2006	US20060280729 Cellular therapy for ocular degeneration
12/14/2006	US20060280727 Dendritic cell isolation methods
12/14/2006	US20060280726 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
12/14/2006	DE10312144B4 Trägermaterial für die Gewebe- und Zellkultur und die Herstellung von Implantatmaterialien Support material for tissue and cell culture and the production of implant materials
12/14/2006	CA2650841A1 Method of profiling a cell population
12/14/2006	CA2613889A1 A cellular therapy for ocular degeneration
12/14/2006	CA2610771A1 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	CA2607841A1 Polypeptides having antimicrobial activity and polynucleotides encoding same
12/13/2006	EP1731614A1 Reversible nuclear genetic system for male sterility in transgenic plants
12/13/2006	EP1731610A1 Proteins imparting boron-tolerance and genes thereof
12/13/2006	EP1731608A1 Marker gene for arthrorheumatism test
12/13/2006	EP1731607A1 shRNA and siRNA expression in a living organism under control of a codon-optimized tetracycline repressor gene
12/13/2006	EP1731605A1 Cancer antigen peptides derived from wt1
12/13/2006	EP1731604A1 Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid
12/13/2006	EP1731601A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE II alpha KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
12/13/2006	EP1731598A1 Methods for cultivating cells and propagating viruses
12/13/2006	EP1731597A1 Selenium-enriched liquid media for the cultivation of siliceous sponges and for biogenic silica production
12/13/2006	EP1731531A2 Multiple cytokine-antibody complexes
12/13/2006	EP1731177A1 Biological tissue sheet, method of forming the same and transplantation method by using the sheet
12/13/2006	EP1731166A2 Streptococcus pneumoniae proteins and vaccines
12/13/2006	EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/13/2006	EP1731144A1 Identification of genes altered in multiple myeloma
12/13/2006	EP1730523A1 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa
12/13/2006	EP1730293A2 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
12/13/2006	EP1730283A1 Method for improving plants
12/13/2006	EP1730278A1 Method for preparation and purification of recombinant proteins
12/13/2006	EP1730272A2 Systems and methods for screening for modulators of neural differentiation
12/13/2006	EP1730269A2 Culture and use of cells that secrete liver secretory factors
12/13/2006	EP1730268A2 Differentiation of stem cells to endoderm and pancreatic lineage
12/13/2006	EP1730267A1 Reverse-flow perfusioin of three-dimensional scaffolds
12/13/2006	EP1730266A2 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations
12/13/2006	EP1730265A2 3d-cardiac tissue engineering for the cell therapy of heart failure
12/13/2006	EP1730264A1 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
12/13/2006	EP1730263A2 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
12/13/2006	EP1730262A2 Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs
12/13/2006	EP1730261A2 Compositions and methods for growth of embryonic stem cells
12/13/2006	EP1730260A2 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses
12/13/2006	EP1730198A2 Adzymes and uses thereof
12/13/2006	EP1730196A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
12/13/2006	EP1730195A2 Estrogen receptors and methods of use
12/13/2006	EP1730193A2 Monoclonal antibodies to gastrin hormone
12/13/2006	EP1730191A2 Immunoglobulins
12/13/2006	EP1730173A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
12/13/2006	EP1729831A1 Preparation of a nucleated cell and/or platelet concentrate from a physiological solution
12/13/2006	EP1729803A2 Therapeutic use of anti-cs1 antibodies

1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1827